RareResearch.AI
← Back to atlas

N396S

AlphaMissense: likely benign (0.20)Uncertain significanceTransmembrane · predicted
AsparagineSerine at position 396 · Cytoplasmic loop 2 · WFS1 (Wolframin)

Interactive 3D Structure

Interactive structure
rotate · zoom · variant + 5 Å neighbors
Fullscreen ↗

Computational Predictions

AlphaMissense
0.204
likely benign
AlphaFold pLDDT
80
model confidence
DynaMut2 ΔΔG
pending
not yet computed
ClinVar
Uncertain significance
Uncertain significance

AlphaMissense + AlphaFold card. This variant is mapped from AlphaMissense pathogenicity and AlphaFold confidence. The DynaMut2 ΔΔG stability prediction and the wild-type/mutant structural comparison (dual-pane + bond network) are computed per-variant and backfill here — they require a DynaMut2 submission, unlike the precomputed AlphaMissense score.

Clinical Evidence

ClinVar classificationUncertain significance
Review statusno assertion criteria provided
Associated conditions
Population frequency (gnomAD v4)Ultra-rare · AF 0.00050%
cDNA changec.1187A>G
ClinVar accessionVCV001284744
Last evaluated1/01/01 00:00

Observed at very low frequency in gnomAD.

Full Variant Card

N396S — WFS1 Molecular Atlas Card

Variant type: Missense Substitution: Asparagine (N) → Serine (S) at position 396 Domain context: Cytoplasmic loop 2


AlphaMissense

  • Pathogenicity score: 0.2038
  • Class: likely benign

AlphaFold confidence

  • pLDDT at residue 396: 80.31

DynaMut2 ΔΔG: not yet computed for this variant — AlphaMissense + AlphaFold confidence shown above. Stability ΔΔG and the wild-type/mutant structural comparison backfill behind this note.


Clinical evidence

  • Classification: Uncertain significance
  • Review status: no assertion criteria provided
  • cDNA change: c.1187A>G
  • ClinVar accession: VCV001284744
  • Last evaluated: 1/01/01 00:00
  • Submissions: 1

Card generated by wolfram-atlas-batch (missense AlphaMissense mint) on 2026-06-08T02:27:33.505645Z. AlphaMissense (Cheng et al. 2023) · AlphaFold model v6 · UniProt O76024.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the N396S PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download N396S PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.